Abstract:Data from EV-D68-infected patients demonstrate that pathological changes in the lower respiratory tract are principally characterized by severe respiratory illness in children and acute flaccid myelitis. However, lack of a suitable animal model for EV-D68 infection has limited the study on the pathogenesis of this critical pathogen, and the development of a vaccine. Ferrets have been widely used to evaluate respiratory virus infections. In the current study, we used EV-D68-infected ferrets as a potential anima… Show more
“…A transient viremia developed in ferrets after intranasal inoculation, and virus-specific RNA was detected in feces from infected animals, neither of which is observed during most human infections. No neurological disease developed, nor did virus replicate in this animal model of EV-D68 infection (60).…”
Section: Discussionmentioning
confidence: 95%
“…Four mouse models of EV-D68 infection have been established (13, 35, 59–61). One model examined the immune response within the respiratory tract elicited after intranasal inoculation with EV-D68 using 8- to 10-week-old wild-type BALB/c mice; however, no virus replication was observed in these animals (61).…”
Since 2014, numerous outbreaks of childhood infections with enterovirus D68 (EV-D68) have occurred worldwide. Most infections are associated with flu-like symptoms, but paralysis may develop in young children. It has been suggested that infection only with recent viral isolates can cause paralysis. To address the hypothesis that EV-D68 has recently acquired neurotropism, murine organotypic brain slice cultures, induced human motor neurons and astrocytes, and mice lacking the alpha/beta interferon receptor were infected with multiple virus isolates. All EV-D68 isolates, from 1962 to the present, can infect neural cells, astrocytes, and neurons. Furthermore, our results show that sialic acid binding does not play a role in EV-D68 neuropathogenesis. The study of EV-D68 infection in organotypic brain slice cultures, induced motor neurons, and astrocytes will allow for the elucidation of the mechanism by which the virus infection causes disease.
“…A transient viremia developed in ferrets after intranasal inoculation, and virus-specific RNA was detected in feces from infected animals, neither of which is observed during most human infections. No neurological disease developed, nor did virus replicate in this animal model of EV-D68 infection (60).…”
Section: Discussionmentioning
confidence: 95%
“…Four mouse models of EV-D68 infection have been established (13, 35, 59–61). One model examined the immune response within the respiratory tract elicited after intranasal inoculation with EV-D68 using 8- to 10-week-old wild-type BALB/c mice; however, no virus replication was observed in these animals (61).…”
Since 2014, numerous outbreaks of childhood infections with enterovirus D68 (EV-D68) have occurred worldwide. Most infections are associated with flu-like symptoms, but paralysis may develop in young children. It has been suggested that infection only with recent viral isolates can cause paralysis. To address the hypothesis that EV-D68 has recently acquired neurotropism, murine organotypic brain slice cultures, induced human motor neurons and astrocytes, and mice lacking the alpha/beta interferon receptor were infected with multiple virus isolates. All EV-D68 isolates, from 1962 to the present, can infect neural cells, astrocytes, and neurons. Furthermore, our results show that sialic acid binding does not play a role in EV-D68 neuropathogenesis. The study of EV-D68 infection in organotypic brain slice cultures, induced motor neurons, and astrocytes will allow for the elucidation of the mechanism by which the virus infection causes disease.
“…These findings support that EV-D68 mostly causes respiratory illness. 35,37,38 EV-D68 also has tropism of motor nerve cells and may lead to neurological involvement (Table 3). 39…”
Section: Clinical Manifestationsmentioning
confidence: 99%
“…Animal study found that EV-D68 infection induces inflammation and diffuse alveolar hemorrhage in the lungs and leads to lung injury at the middle and late stages of infection. 38 Clinically, patients may have severe respiratory illness which needs hospitalization and even intensive care or ventilator support. 19,24 Common features of hospitalized patients include tachypnea, hypoxia, asthma attack, pneumonia or acute respiratory distress syndrome.…”
Section: Mild To Moderate Respiratory Illnessmentioning
Enterovirus D68 was first identified in 1962 and caused a worldwide outbreak starting from the North America in 2014. Enterovirus D68 has been in continuous circulation among many countries recently, including Taiwan. Reports also reveal high seroprevalence, which indicates that the disease burden of enterovirus D68 may be underestimated via viral culture or polymerase chain reaction results. Although most infected cases have mild respiratory illness, severe complications including acute flaccid myelitis and acute respiratory distress syndrome have also been reported. In the position of an emerging pathogen, enterovirus D68 poses a threat to public health and may cause devastating diseases. Diverse severity of neurological sequelae remains inevitable among acute flaccid myelitis patients, but no curable treatment is available currently. According to the management suggestions of the American Centers of Disease Control, uses of corticosteroids and plasmapheresis are either preferred or avoided and intravenous immunoglobulin also has no clear indication in the treatment for acute flaccid myelitis. In this review article, we provide information about the epidemiology, clinical recognition and treatment strategy of enterovirus D68. Better understanding of this disease is the foothold for advanced investigation and monitoring in the future.
“…Previously Patel et al found that four to six week-old cotton rats were permissive to transient EVD68 replication following intranasal infection; however, the infectious virus was cleared from the nose and lung tissues 48 h post infection, and no clinical symptoms or death were observed in the rats [ 20 ]. Similarly, intranasal infection of EVD68 resulted in minimal clinical symptoms in ferrets [ 21 ]. Therefore, the two animal models are not suitable for evaluation of EVD68 vaccines and antiviral agents.…”
In recent years, enterovirus D68 (EVD68) has been reported increasingly to be associated with severe respiratory tract infections and acute flaccid myelitis (AFM) in children all over the world. Yet, no effective vaccines or antiviral drugs are currently available for EVD68. Although several experimental animal models have been developed, immunogenicity and protective efficacy of inactivated EVD68 vaccines has not been fully evaluated. To promote the development of vaccines, we established an Institute of Cancer Research (ICR) suckling mouse model of EVD68 infection in this study. The results showed that ICR neonatal mice up to about nine days of age were susceptible to infection with EVD68 clinical strain US/MO/14-18947 by intraperitoneal injection. The infected mice exhibited progressive limb paralysis prior to death and the mortality of mice was age- and virus dose-dependent. Tissue viral load analysis showed that limb muscle and spinal cord were the major sites of viral replication. Moreover, histopathologic examination revealed the severe necrosis of the limb and juxtaspinal muscles, suggesting that US/MO/14-18947 has a strong tropism toward muscle tissues. Additionally, β-propiolactone-inactivated EVD68 vaccine showed high purity and quality and induced robust EVD68-specific neutralizing antibody responses in adult mice. Importantly, results from both antisera transfer and maternal immunization experiments clearly showed that inactivated EVD68 vaccine was able to protect against lethal viral infection in the mouse model. In short, these results demonstrate the successful establishment of the mouse model of EVD68 infection for evaluating candidate vaccines against EVD68 and also provide important information for the development of inactivated virus-based EVD68 vaccines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.